Statistics for A phase I trial of hypoxoside as an oral prodrug for cancer therapy : absence of toxicity

Total visits

views
A phase I trial of hypoxoside as an oral prodrug for cancer therapy : absence of toxicity 0

Total visits per month

views
November 2023 0
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0

File Visits

views
smit_phase_1995.pdf 29